Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
9.01
-0.11 (-1.21%)
At close: Jun 27, 2025, 4:00 PM
9.04
+0.03 (0.33%)
After-hours: Jun 27, 2025, 6:54 PM EDT
Viatris Employees
Viatris had 32,000 employees as of December 31, 2024. The number of employees decreased by 6,000 or -15.79% compared to the previous year.
Employees
32,000
Change (1Y)
-6,000
Growth (1Y)
-15.79%
Revenue / Employee
$447,819
Profits / Employee
-$118,441
Market Cap
10.57B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VTRS News
- 2 days ago - Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia - PRNewsWire
- 15 days ago - Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025 - PRNewsWire
- 18 days ago - Viatris Inc. (VTRS) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 23 days ago - Viatris Inc. (VTRS) Presents at Jefferies Global Healthcare Conference Transcript - Seeking Alpha
- 25 days ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - GlobeNewsWire
- 26 days ago - Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions - PRNewsWire
- 4 weeks ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - PRNewsWire
- 4 weeks ago - VTRS CLASS NOTICE: Viatris Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS) - GlobeNewsWire